Security Snapshot

TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) Institutional Ownership

CUSIP: 881624209

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

675

Shares (Excl. Options)

731.33MFull value: 731,332,014 · shares · 30 Jun 2026

Price

$33.88

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Ordinary Shares, par value NIS 0.01 per share
Symbol
TEVA on NYSE
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
731,332,014
Latest holder snapshot 5 signals
Total 13F value
$24,722,853,978
Portfolio coverage rank
0.02%
Share change
+58,647,959
Value change
+$2,000,325,769
Number of holders
675
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
1,148,777,709
SEC-reported price per share
$39.17
Insider filing price
$39.17
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share is tracked under CUSIP 881624209.
  • 675 institutions reported positions in Q2 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 651 to 675 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $20.14BFull value: $20,142,014,184 · USD · 31 Mar 2026
    to
    $24.72BFull value: $24,722,853,978 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 675 institutions filings for Q2 2026.

Open SEC evidence

Security key

881624209

13F reference period

Q2 2026

13F holders

675

13D/G owners

3

CIK / CUSIP context first

Open Q2 2026 holders TEVA full holder history TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings TEVA PHARMACEUTICAL INDUSTRIES LTD company facts TEVA PHARMACEUTICAL INDUSTRIES LTD insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
TEVA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Migdal Insurance & Financial Holdings Ltd. 5.4% $2,022,794,213 61,689,363 Migdal Insurance & Financial Holdings Ltd 31 Dec 2025
MENORA MIVTACHIM HOLDINGS LTD. 5% $961,943,099 57,395,173 Menora Mivtachim Holdings Ltd 16 Jul 2025
Phoenix Financial Ltd. 5% $961,741,722 57,383,158 Phoenix Financial Ltd. 14 Jul 2025
As of 30 Jun 2026, 675 institutional investors reported holding
731.33MFull value: 731,332,014 · shares · 30 Jun 2026
shares of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA). This represents 64% of the company’s total
1.15BFull value: 1,148,777,709 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
47%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 5.6% 63,894,301 -1.9% 0.03% $2,164,738,902
Harel Insurance Investments & Financial Services Ltd. 4.2% 48,138,805 +4.7% 7.9% $1,630,943,000
Phoenix Financial Ltd. 3.7% 42,933,367 +0.36% 9.9% $1,454,582,474
WCM INVESTMENT MANAGEMENT, LLC 3.6% 41,315,232 +1.2% 2.5% $1,376,210,378
Clal Insurance Enterprises Holdings Ltd 3.5% 40,596,506 +5.6% 6.1% $1,366,377,000
MENORA MIVTACHIM HOLDINGS LTD. 3.5% 39,854,383 +0.58% 5.3% $1,350,266,496
Migdal Insurance & Financial Holdings Ltd. 3.4% 38,922,212 +2.7% 8.4% $1,318,684,543
NORGES BANK 2.8% 32,299,753 0.11% $1,094,315,632
FMR LLC 2.6% 30,258,016 -8.7% 0.04% $1,025,141,579
Lingotto Investment Management LLP 1.8% 20,205,943 -27% 15% $684,577,349
STATE STREET CORP 1.6% 18,936,548 +6.4% 0.02% $641,570,246
Rubric Capital Management LP 1.4% 15,575,000 +2.1% 4.8% $527,681,000
Capital World Investors 1.1% 12,536,035 +42% 0.05% $424,720,866
Altshuler Shaham Ltd 1.1% 12,466,895 +8.8% 5.2% $411,809,423
GEODE CAPITAL MANAGEMENT, LLC 1% 11,607,196 +9.9% 0.02% $391,014,749
MEITAV INVESTMENT HOUSE LTD 0.87% 9,947,045 2.3% $336,876,210
NORTHERN TRUST CORP 0.69% 7,956,873 +4.2% 0.03% $269,578,857
WELLINGTON MANAGEMENT GROUP LLP 0.67% 7,671,157 +5.8% 0.04% $259,898,799
JPMORGAN CHASE & CO 0.61% 6,981,234 +3.2% 0.01% $232,544,997
MORGAN STANLEY 0.61% 6,968,719 -6.2% 0.01% $236,100,276
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 0.57% 6,593,221 +362% 0.67% $223,369,747
Alyeska Investment Group, L.P. 0.54% 6,257,579 +13% 0.55% $212,006,777
GOLDMAN SACHS GROUP INC 0.53% 6,129,240 +27% 0.02% $207,658,651
BESSEMER GROUP INC 0.49% 5,581,600 +28% 0.26% $189,104,000
Polar Capital Holdings Plc 0.45% 5,212,749 +0.73% 0.5% $176,607,936

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 204,763 $7,618,703 -$1,644,887,763 $39.17 8
2026 Q2 731,332,014 $24,722,853,978 +$2,000,325,769 $33.88 675
2026 Q1 672,325,925 $20,142,014,184 -$615,161,432 $30.12 651
2025 Q4 686,977,855 $21,442,593,594 +$1,230,700,950 $31.21 628
2025 Q3 657,155,100 $13,261,324,401 -$1,074,548,979 $20.20 544
2025 Q2 712,590,449 $11,941,932,547 +$36,824,124 $16.76 533
2025 Q1 711,693,842 $10,931,543,829 +$519,379,518 $15.37 553
2024 Q4 665,647,648 $14,670,317,479 +$818,691,314 $22.04 576
2024 Q3 620,854,841 $11,183,045,547 +$327,878,111 $18.02 537
2024 Q2 607,728,519 $9,874,096,775 +$630,049,704 $16.25 528
2024 Q1 570,414,049 $8,044,022,392 -$52,732,472 $14.11 474
2023 Q4 577,047,792 $6,069,688,726 +$223,053,462 $10.44 442
2023 Q3 554,042,366 $5,650,669,709 +$626,794,069 $10.20 427
2023 Q2 494,500,315 $3,725,733,619 -$615,772,920 $7.53 415
2023 Q1 558,872,500 $4,939,868,087 -$36,845,034 $8.85 431
2022 Q4 546,063,896 $4,978,922,006 -$17,646,117 $9.12 412
2022 Q3 560,076,320 $4,512,924,774 +$430,391,292 $8.07 395
2022 Q2 505,606,590 $3,800,507,049 -$46,832,800 $7.52 423
2022 Q1 514,571,916 $4,831,771,215 +$15,212,208 $9.39 420
2021 Q4 505,268,193 $4,044,921,275 -$275,589,149 $8.01 404
2021 Q3 527,166,334 $5,134,182,484 -$316,368,771 $9.74 408
2021 Q2 560,418,706 $5,548,640,366 -$132,495,361 $9.90 423
2021 Q1 572,281,687 $6,602,414,033 +$11,656,292 $11.54 432
2020 Q4 569,047,097 $5,481,032,100 +$43,379,354 $9.65 425
2020 Q3 567,029,372 $5,101,188,907 -$198,579,913 $9.01 421
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .